Fred Gatali‏

Stock Analyst at Raymond James

(n/a)
# 4,896
Out of 5,014 analysts
1
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by Fred Gatali‏

PharmaCorp Rx Inc.
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $0.70
Current: $0.42
Upside: +66.67%